Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
180%
upside
4 price targets
|
0
%
|
|
|
|
178%
upside
5 price targets
|
0
%
|
|
|
|
171%
upside
4 price targets
|
0
%
|
|
|
54
Coya Therapeutics
COYA
$126M
|
170%
upside
4 price targets
|
0
%
|
|
|
170%
upside
5 price targets
|
0
%
|
|
|
|
167%
upside
4 price targets
|
0
%
|
|
|
|
165%
upside
4 price targets
|
0
%
|
|
|
|
165%
upside
6 price targets
|
0
%
|
|
|
|
163%
upside
4 price targets
|
0
%
|
|
|
|
157%
upside
3 price targets
|
0
%
|
|
|
61
Taysha Gene Therapies
TSHA
$1.17B
|
157%
upside
7 price targets
|
0
%
|
|
|
152%
upside
9 price targets
|
0
%
|
|
|
|
152%
upside
6 price targets
|
0
%
|
|
|
|
151%
upside
5 price targets
|
0
%
|
|
|
|
142%
upside
3 price targets
|
0
%
|
|
|
|
140%
upside
5 price targets
|
0
%
|
|
|
|
139%
upside
3 price targets
|
0
%
|
|
|
|
137%
upside
4 price targets
|
0
%
|
|
|
|
134%
upside
3 price targets
|
0
%
|
|
|
|
133%
upside
3 price targets
|
0
%
|
|
|
|
129%
upside
4 price targets
|
0
%
|
|
|
|
129%
upside
7 price targets
|
0
%
|
|
|
|
127%
upside
8 price targets
|
0
%
|
|
|
|
126%
upside
5 price targets
|
0
%
|
|
|
|
125%
upside
7 price targets
|
0
%
|
|